ADVERTISEMENT
While there was no heightened risk among 18-to-34-year olds prescribed the drug, the risk of dementia more than doubled and MCI more than tripled among 35–49 year old prescribed it.
Patients given 12 or more prescriptions were at even greater risk, the scientists found.